Table 1.
Sex | Age | Diagnosis | Location tumor | MGMT† |
---|---|---|---|---|
♂ | 64 | Recurrent‡ | Occipital (R) | - |
♀ | 74 | Newly diagnosed | Frontal (R) | + |
♀ | 85 | Newly diagnosed | Temporofrontal (R) | - |
♀ | 51 | Newly diagnosed | Frontal (R) | Unknown |
♀ | 62 | Newly diagnosed | Temporal (R) | - |
♀ | 59 | Newly diagnosed | Frontal (R) | - |
♂ | 50 | Newly diagnosed | Temporal (L) | - |
♂ | 62 | Newly diagnosed | Temporal (R) | + |
All patients were diagnosed with glioblastoma multiforme (World Health Organization grade IV astrocytoma). †, methylguanine methyltransferase (MGMT) promotor hypermethylation; ‡, patient received treatment prior to resection of the recurrent tumor. L, left; R, right.